KYIV. April 6 (Interfax-Ukraine) – Ukraine’s Antimonopoly Committee has permitted FI&P Holdings Limited (Cyprus) to indirectly acquire shares in the share capital of Farmak Group N.V. (the Netherlands). This will grant over 50% of the votes in the management body of the company.
The press service of the committee reported that the acquisition will be settled via Farmak Holdings Sarl (Luxembourg).
According to the National Commission for Securities and the Stock Market of Ukraine, 25% and 42.5% of shares in public joint-stock company Farmak (Kyiv) as of Q4 2015 belonged to Farmak Group N.V. and 11.27% to Farmak International Holding GmbH (Austria).
Farmak produces up to 200 different medicines.
By 2020, the company plans to boost sales to $1 billion and reduce the share of its sales in Ukraine from 80% to 60% of total sales. The company plans to ensure 10% of its sales on well regulated markets of Eastern Europe and the CIS each.
